BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6182397)

  • 21. Effects of diltiazem on experimental myocardial ischemia and on left ventricular performance.
    Clozel JP; Théroux P; Bourassa MG
    Circ Res; 1983 Feb; 52(2 Pt 2):I120-8. PubMed ID: 6831646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of diltiazem on the coronary haemodynamic and cardiac functional effects produced by intracoronary administration of endothelin-1 in the anaesthetized dog.
    Nichols AJ; Koster PF; Ohlstein EH
    Br J Pharmacol; 1990 Mar; 99(3):597-601. PubMed ID: 2184913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic effects of intravenous diltiazem with impaired left ventricular function.
    Materne P; Legrand V; Vandormael M; Collignon P; Kulbertus HE
    Am J Cardiol; 1984 Oct; 54(7):733-7. PubMed ID: 6486022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of diltiazem and nifedipine on systemic and coronary hemodynamics and ischemic responses during transient coronary artery occlusion in patients.
    Kern MJ; Deligonul U; Labovitz A
    Am Heart J; 1990 Jan; 119(1):47-54. PubMed ID: 2296873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Coronary sinus blood flow after intracoronary or intravenous administration of bisoprolol in coronary disease].
    Gonschior P; Fleuchaus M; Larisch K; Stäblein A; Höfling B
    Dtsch Med Wochenschr; 1995 Aug; 120(34-35):1147-50. PubMed ID: 7656846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic tolerability and anti-ischemic efficacy of high dose intravenous diltiazem in patients with normal versus impaired ventricular function.
    Remme WJ; Krauss XH; van Hoogenhuyze DC; Kruyssen DA
    J Am Coll Cardiol; 1993 Mar; 21(3):709-20. PubMed ID: 8436753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of diltiazem on myocardial blood flow.
    Bache RJ; Dymek DJ
    Circulation; 1982 Jan; 65(1 Pt 2):I19-26. PubMed ID: 7053295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute antiischaemic properties of high dosages of intravenous diltiazem in humans in relation to its coronary and systemic haemodynamic effects.
    Remme WJ; van Hoogenhuyze DC; Hofman A; Storm CJ; Krauss XH; Kruyssen HA
    Eur Heart J; 1987 Sep; 8(9):965-74. PubMed ID: 3665956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of diltiazem on coronary reactive hyperemia in patients with flow-limiting coronary artery stenosis.
    Foult JM; Nitenberg A; Blanchet F; Zouiouèche S
    Am Heart J; 1986 Dec; 112(6):1232-7. PubMed ID: 3788770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved myocardial oxygen utilization by diltiazem in patients.
    Kern MJ; Walsh RA; Barr WK; Porter CB; O'Rourke RA
    Am Heart J; 1985 Nov; 110(5):986-90. PubMed ID: 4061275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of intravenous diltiazem on cardiocirculatory dynamics and cardiac output distribution in conscious spontaneously hypertensive rats.
    Flaim SF; Newman ED; Annibali JA
    J Cardiovasc Pharmacol; 1986; 8(2):241-51. PubMed ID: 2422460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of diltiazem on coronary hemodynamics and its clinical significance.
    Yabe Y; Abe H; Yoshimura S; Tsuzuku A; Hasegawa M; Kashiwakura Y; Arai C; Kawasaki T; Abe M
    Jpn Heart J; 1979 Jan; 20(1):83-93. PubMed ID: 449045
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of diltiazem on extent of ultimate myocardial injury resulting from temporary coronary artery occlusion in dogs.
    Bush LR; Romson JL; Ash JL; Lucchesi BR
    J Cardiovasc Pharmacol; 1982; 4(2):285-96. PubMed ID: 6175813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of diltiazem on coronary flow reserve in humans.
    Rossen JD; Simonetti I; Marcus ML; Braun P; Winniford MD
    Circulation; 1989 Nov; 80(5):1240-6. PubMed ID: 2805261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional coronary hemodynamic effects of diltiazem in man.
    Vigorito C; Giordano A; De Caprio L; Canonico V; Ferraro P; Farese N; Silvestri P; Catanzaro M; Rengo F
    Am Heart J; 1988 Sep; 116(3):799-805. PubMed ID: 3414493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracoronary-administered urapidil does not influence myocardial contractility, metabolic activity, or coronary sinus blood flow in humans.
    van der Stroom JG; van Wezel HB; Piek JJ; Kal JE; van der Linden R; Vergroesen I; Pfaffendorf M; van Zwieten PA
    J Cardiothorac Vasc Anesth; 1999 Dec; 13(6):684-9. PubMed ID: 10622649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collateral blood flow following acute coronary artery occlusion: comparison of a new intracellular calcium antagonist (KT-362) and diltiazem.
    Farber NE; Gross GJ
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):66-72. PubMed ID: 2475718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial blood flow following experimental coronary occlusion. Effects of diltiazem.
    Nakamura M; Kikuchi Y; Senda Y; Yamada A; Koiwaya Y
    Chest; 1980 Jul; 78(1 Suppl):205-9. PubMed ID: 7398408
    [No Abstract]   [Full Text] [Related]  

  • 39. Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine.
    Zyvoloski MG; Brooks HL; Gross GJ; Warltier DC
    J Pharmacol Exp Ther; 1982 Aug; 222(2):494-500. PubMed ID: 7097568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemodynamic effects of intravenous diltiazem at rest and exercise in patients with coronary artery disease.
    Legrand V; Hastir F; Vandormael M; Collignon P; Kulbertus HE
    Eur Heart J; 1984 Jun; 5(6):456-63. PubMed ID: 6745287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.